Pure Global
NCT06130423

Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Health Staff

Multi-method Pilot Study to Evaluate the Interest of Music Therapy Associated to Nicotine Replacement Therapy (NRT) Versus NRT Alone on Craving Related to Smoking Cessation in Health Staff.
Poitiers University Hospital·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
Music intervention
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Poitiers University Hospital
Timeline & enrollment
Phase
N/A
Start date
Jan 10, 2024
End date
Jan 10, 2026
Enrollment
50 participants
Primary outcome

Assess if Music therapy associated to NRT decrease tabacco craving compared to NRT alone

Summary

The study is a randomized, controlled trial comparing music therapy associated to NRT versus
 NRT alone to evaluate the value of music therapy in improving the management of craving among
 50 health staff smokers. This pilot multi-method study will combine the methodology of
 clinical trial with qualitative techniques used in social sciences to show the interest of a
 digital music therapy tool, adapted to a health staff audience.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06130423
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06130423 through Pure Global AI's free database. This phase not specified trial is sponsored by Poitiers University Hospital and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.